Tanzania National Institute for Medical Research
Welcome,         Profile    Billing    Logout  
 4 Trials 
5 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Ross, David A
MANIFEST-2, NCT04603495 / 2020-001989-10: Phase 3 Study of Pelabresib (CPI-0610) in Myelofibrosis (MF)

Jan 2024 - Dec 2024: Approval for myelofibrosis
Hourglass Jul 2024 - Dec 2024 : Regulatory submission in EU for 1L myelofibrosis
Jan 2024 - Mar 2024: From MANIFEST-2 trial in combination with ruxolitinib as a first-line treatment for patients with myelofibrosis
Feb 2024 - Feb 2024: Completion of P2b trial for JIA
Feb 2024 - Feb 2024: Exclusivity expiry in US
Active, not recruiting
3
430
Europe, Canada, US, RoW
Pelabresib, Ruxolitinib, Placebo
Constellation Pharmaceuticals
Myelofibrosis, Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis
08/23
12/27
KER050-MD-201, NCT04419649 / 2021-001838-19: A Study of KER-050 to Treat Anemia Due to Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes

Hourglass Dec 2024 - Dec 2024 : Additional data for very low, low, or intermediate risk myelodysplastic syndrome
Hourglass Jul 2023 - Dec 2023 : Enrollment completion of transfusion dependent cohorts of trial for low, or intermediate risk MDS
Recruiting
2
140
Europe, US, RoW
KER-050
Keros Therapeutics, Inc., Keros Therapeutics, Inc.
Myelodysplastic Syndromes, Cytopenia
06/25
11/25
NCT06560853: Evaluation of a Comprehensive School Health Programme in Zambia

Active, not recruiting
N/A
28700
RoW
Comprehensive School Health Programme, SHP, Deworming and vitamin A supplementation delivery, Deworming
London School of Economics and Political Science, University of Virginia, Healthy Learners, United States Agency for International Development (USAID), Medical Research Council
Helminth Infection, Malaria, Schistosomiasis, Anemia, UTI, Diarrhea, Skin Rash, Cough
11/26
11/26
LAMBDA 002, NCT05170425: (Lung Registry) Study

Active, not recruiting
N/A
154
US
Prospera
Natera, Inc.
Lung Transplant Rejection
08/26
05/27
Changalucha, John M
HPV, NCT06129253: Global Burden Estimation of Human Papillomavirus (GLOBE-)

Recruiting
N/A
29750
RoW
Urine Sample Collection, Self-collected Vaginal Swab, Blood Samples
International Vaccine Institute, London School of Hygiene and Tropical Medicine, Karolinska Institutet, Centers for Disease Control and Prevention
HPV Infection
12/27
12/27

Download Options